Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AARDAardvark Therapeutics, Inc.

Nasdaq · CIK 0001774857
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts150

Identity from submissions API

NameAardvark Therapeutics, Inc.
CIK0001774857
TickersAARD
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN821606367
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(858) 225-7696
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
4370 LA JOLLA VILLAGE DRIVE
SUITE 1050
SAN DIEGO
CA
92122
CA
Mailing address
4370 LA JOLLA VILLAGE DRIVE
SUITE 1050
SAN DIEGO
CA
92122
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

120 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-128212 005-94897 261560165 34 18227
2026-11-13 8-K 8-K 2.02,9.01 0001193125-26-459373 001-42513 261549114 34 315098 1 1
2026-11-13 10-Q 10-Q 0001193125-26-458957 001-42513 261548682 34 9653159 1 1
2026-11-10 4 4 0001193125-26-455757 18655
2026-11-10 4 4 0001193125-26-455737 18681
2026-11-10 4 4 0001193125-26-455719 18660
2026-10-23 8-K 8-K 8.01,9.01 0001193125-26-429509 001-42513 261479968 34 11927901 1 1
2026-10-22 8-K 8-K 8.01,9.01 0001193125-26-428943 001-42513 261479074 34 199478 1 1
2026-10-08 4 4 0001193125-26-418022 5546
2026-10-08 3 3 0001193125-26-418016 16630
2026-10-08 8-K 8-K 5.02,8.01,9.01 0001193125-26-417935 001-42513 261450042 34 186894 1 1
2026-09-11 4 4 0001193125-26-389564 7093
2026-09-11 144 xsl144X01/primary_doc.xml 0001950047-26-009373 001-42513 261374998 33 6321
2026-09-10 144 xsl144X01/primary_doc.xml 0001950047-26-009316 001-42513 261371998 33 6140
2026-08-21 4 4 0001193125-26-361489 5520
2026-08-21 4 4 0001193125-26-361486 5497
2026-08-21 4 4 0001193125-26-361482 5504
2026-08-21 4 4 0001193125-26-361481 5596
2026-08-17 8-K 8-K 5.07 0001193125-26-354053 001-42513 261286766 34 175672 1 1
2026-08-11 10-Q 10-Q 0001193125-26-344987 001-42513 261264327 34 7248415 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344978 001-42513 261264282 34 303109 1 1
2026-07-10 ARS ARS 0001193125-26-300897 001-42513 261168853 34 5613840
2026-07-10 DEF 14A DEF 14A 0001193125-26-300874 001-42513 261168773 34 12554769 1 1
2026-06-29 PRE 14A PRE 14A 0001193125-26-288409 001-42513 261135712 34 12191260 1 1
2026-06-12 8-K 8-K 5.02,9.01 0001193125-26-269377 001-42513 261086541 34 159237 1 1
2026-05-14 8-K 8-K 8.01,9.01 0001193125-26-224069 001-42513 26979140 34 186315 1 1
2026-05-07 10-Q 10-Q 0001193125-26-210675 001-42513 26951283 34 7632647 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-210664 001-42513 26951246 34 280942 1 1
2026-04-03 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001083 333-294537 26839466 33 1783
2026-04-03 424B5 424B5 0001193125-26-142105 333-294537 26838089 33 894083
2026-03-30 CORRESP filename1.htm 0001193125-26-131825 14518
2026-03-25 UPLOAD filename1.pdf 0000000000-26-003024 333-294537 40157
2026-03-24 8-K 8-K 1.01,9.01 0001193125-26-120164 001-42513 26783725 34 161454 1 1
2026-03-24 S-8 S-8 0001193125-26-120120 333-294546 26783694 33 390174 1 1
2026-03-23 S-3 S-3 0001193125-26-119973 333-294537 26783197 33 3452109 1 1
2026-03-23 10-K 10-K 0001193125-26-119770 001-42513 26782477 34 36833384 1 1
2026-03-23 8-K 8-K 2.02,9.01 0001193125-26-119727 001-42513 26782294 34 410252 1 1
2026-02-27 8-K 8-K 8.01,9.01 0001193125-26-082787 001-42513 26700484 34 192952 1 1
2026-02-12 8-K 8-K 5.02,8.01,9.01 0001193125-26-047757 001-42513 26623526 34 319105 1 1
2026-02-11 4 4 0001193125-26-047317 5415
2026-02-11 4 4 0001193125-26-047315 5440
2026-02-11 4 4 0001193125-26-047316 5439
2026-02-10 8-K 8-K 8.01,9.01 0001193125-26-043764 001-42513 26613523 34 196395 1 1
2026-01-12 8-K 8-K 8.01,9.01 0001193125-26-009862 001-42513 26524811 34 11924368 1 1
2025-12-12 4 4 0001193125-25-318070 4444
2025-12-12 4 4 0001193125-25-318069 5131
2025-12-10 8-K 8-K 8.01,9.01 0001193125-25-314364 001-42513 251562564 34 218439 1 1
2025-11-13 10-Q 10-Q 0001193125-25-280260 001-42513 251479027 34 28774601 1 1
2025-11-13 8-K 8-K 2.02,9.01 0001193125-25-280235 001-42513 251478844 34 334275 1 1
2025-11-06 8-K 8-K 8.01,9.01 0001193125-25-267402 001-42513 251455418 34 26554570 1 1
2025-11-04 8-K 8-K 7.01,8.01,9.01 0001193125-25-264748 001-42513 251449403 34 2529940 1 1
2025-10-16 4 4 0001193125-25-241647 7560
2025-10-16 4 4 0001193125-25-241643 6895
2025-10-09 8-K 8-K 8.01,9.01 0001193125-25-234722 001-42513 251383250 34 326982 1 1
2025-09-16 4 4 0001193125-25-204233 7625
2025-09-15 144 xsl144X01/primary_doc.xml 0001950047-25-007102 001-42513 251314370 33 6646
2025-09-12 4 4 0001193125-25-202490 9639
2025-09-10 4 4 0001193125-25-200226 5053
2025-09-03 8-K 8-K 8.01,9.01 0000950170-25-112645 001-42513 251287531 34 9124712 1 1
2025-09-02 144 xsl144X01/primary_doc.xml 0001950047-25-006593 001-42513 251285433 33 5866
2025-08-29 4 4 0001193125-25-192747 7567
2025-08-28 144 xsl144X01/primary_doc.xml 0001950047-25-006518 001-42513 251274104 33 5087
2025-08-13 S-8 S-8 0000950170-25-108176 333-289592 251213128 33 371131 1 1
2025-08-13 10-Q 10-Q 0000950170-25-108116 001-42513 251212445 34 18315964 1 1
2025-08-13 8-K 8-K 2.02,9.01 0000950170-25-108082 001-42513 251212241 34 330264 1 1
2025-08-12 8-K 8-K 8.01,9.01 0000950170-25-107320 001-42513 251206800 34 470530 1 1
2025-06-13 4 4 0000950170-25-086147 5410
2025-06-13 4 4 0000950170-25-086146 5354
2025-06-13 4 4 0000950170-25-086145 5438
2025-06-13 4 4 0000950170-25-086141 5234
2025-06-13 4 4 0000950170-25-086140 5372
2025-06-13 4 4 0000950170-25-086143 5413
2025-06-13 4 4 0000950170-25-086139 5436
2025-06-13 4 4 0000950170-25-086138 5214
2025-05-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072801 005-94897 25954905 34 113739
2025-05-14 10-Q 10-Q 0000950170-25-071560 001-42513 25946696 34 8676235 1 1
2025-05-14 8-K 8-K 2.02,9.01 0000950170-25-071477 001-42513 25946142 34 291836 1 1
2025-03-31 10-K 10-K 0000950170-25-047835 001-42513 25794187 34 26832605
2025-03-31 8-K 8-K 2.02,9.01 0000950170-25-047769 001-42513 25793594 34 292342 1 1
2025-02-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-016592 005-94897 25658495 34 27679
2025-02-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-005246 005-94897 25657202 34 19469
2025-02-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-016266 005-94897 25654135 34 11445
2025-02-19 4 4 0000950170-25-023409 22553
2025-02-19 4 4 0000950170-25-023311 7791
2025-02-19 4 4 0000950170-25-023287 13285
2025-02-19 4 4 0000950170-25-023253 8959
2025-02-19 4 4 0000950170-25-023243 8318
2025-02-19 4 xslF345X05/form4.xml 0000929638-25-000822 11672
2025-02-14 8-K 8-K 5.03,8.01,9.01 0001193125-25-027245 001-42513 25628062 34 206011 1 1
2025-02-13 S-8 S-8 0001193125-25-026172 333-284915 25621399 33 340314
2025-02-13 424B4 424B4 0001193125-25-026060 333-284440 25620211 33 8927322
2025-02-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000422 333-284440 25616921 33 1790
2025-02-12 3 3 0000950170-25-019187 14302
2025-02-12 3 3 0000950170-25-019173 15031
2025-02-12 3 3 0000950170-25-019166 21572
2025-02-12 3 3 0000950170-25-019165 17915
2025-02-12 3 3 0000950170-25-019159 16621
2025-02-12 3 3 0000950170-25-019156 15703
2025-02-12 3 3 0000950170-25-019150 8239
2025-02-12 3 3 0000950170-25-019145 16488
2025-02-12 3 3 0000950170-25-019119 18447
2025-02-12 3 3 0000950170-25-019108 18794
2025-02-12 3 xslF345X02/form3.xml 0000929638-25-000679 7529
2025-02-12 CERT 8A_Cert_AARD.pdf 0001354457-25-000098 001-42513 25614054 34 249025
2025-02-10 8-A12B 8-A12B 0001193125-25-023571 001-42513 25605656 34 13902
2025-02-10 CORRESP filename1.htm 0001193125-25-023550 10855
2025-02-10 CORRESP filename1.htm 0001193125-25-023543 7915
2025-02-06 S-1/A S-1/A 0001193125-25-021764 333-284440 25597262 33 10538270
2025-01-31 CORRESP filename1.htm 0001193125-25-018390 95975
2025-01-23 S-1 S-1 0001193125-25-011499 333-284440 25550825 33 9941617
2024-12-23 DRS/A filename1.htm 0000950123-24-012332 377-07518 241569089 33 9094953
2024-12-20 DRSLTR filename1.htm 0000950123-24-012333 23110
2024-12-10 UPLOAD filename1.pdf 0000000000-24-013594 377-07518 43839
2024-11-27 DRSLTR filename1.htm 0000950123-24-012128 50573
2024-11-27 DRS/A filename1.htm 0000950123-24-012127 377-07518 241512535 33 8339435
2024-11-21 UPLOAD filename1.pdf 0000000000-24-012962 377-07518 56942
2024-10-24 DRS filename1.htm 0000950123-24-009882 377-07518 241390964 33 7963820
2024-05-15 D xslFormDX01/primary_doc.xml 06b 0001774857-24-000001 021-513397 24949455 33 9789
2021-06-07 D xslFormDX01/primary_doc.xml 06b 0001774857-21-000002 021-402004 21999955 33 9705
2019-05-24 D xslFormDX01/primary_doc.xml 06b 0001774857-19-000001 021-340343 19852686 33 7358

Latest XBRL company facts

One latest value per concept from companyfacts (150 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 21.89M 2026-11-02 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
dei EntityPublicFloat Entity Public Float USD 162.90M 2025-06-30 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.59M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 137,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 228.69M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 5.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 5.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 2.37M 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-280260
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001193125-25-280260
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap Assets Assets USD 64.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AssetsCurrent Assets, Current USD 64.11M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 81,000 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 0 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 62.86M 2025-12-31 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 28.42M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071560
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 28.44M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071560
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 28.73M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210675
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 28.75M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-210675
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 60.34M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 60.30M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 60.34M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 13.28M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 4.07M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 490.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 21.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 21.89M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -55.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 138,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 38.66M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3.73M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsInvestments Deferred Tax Assets, Investments USD 1.30M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 23.50M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.76M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 38.52M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 7,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 32,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.52 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.274 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.017 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.024 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.092 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 3.01M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 14.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 15.77M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -12.09M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 221,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -136,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 5.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -483,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -315,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap InterestAndDividendIncomeOperating Interest and Dividend Income, Operating USD 2.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 2.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 10.57M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 458,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 458,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 17,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap Liabilities Liabilities USD 7.19M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 64.80M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap LiabilitiesCurrent Liabilities, Current USD 7.03M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 288,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 63.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -50.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -55.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OperatingExpenses Operating Expenses USD 57.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -57.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 900,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 441,000 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 413,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 159,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OperatingLeasePayments Operating Lease, Payments USD 300,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 532,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.07 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 359,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 162,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD -81,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -81,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 636,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 3.76M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 259,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 63.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 42.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -171.08M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 446,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 5.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 1.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.84 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap ShortTermInvestments Short-term Investments USD 13,000 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 57.61M 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.118 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2,950 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 126.76M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 259,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 87.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 29,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -19,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.51M 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 86,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 20.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-23 0001193125-26-119770
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 21.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 5,402 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 21.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-13 0001193125-26-458957

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →